.jpg)
.jpeg)
Most U.S. employers don't cover weight loss drugs — and fewer plan on doing so
Less than a fifth of large employers in the U.S. include coverage for the popular but pricey weight loss drugs Wegovy and Zepbound, a KFF survey finds.
Less than a fifth of large employers in the U.S. include coverage for the popular but pricey weight loss drugs Wegovy and Zepbound, a KFF survey finds.
What's Your Reaction?
.gif)